Daridorexant - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > Daridorexant - Global Top Players Market Share and Ranking 2025

Daridorexant - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-27
Report Id: 2855319
Industry: Pharma & Healthcare
Report Page: 92
Chart: 93

PDF Download

Publication Date: 2025-11-27
Report Id: 2855319
Industry: Pharma & Healthcare
Report Page: 92
Chart: 93

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Daridorexant Definition
1.2 Global Daridorexant Market Size and Forecast
1.2.1 By Consumption Value, Global Daridorexant Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Daridorexant Market Size, 2020-2031
1.2.3 Global Daridorexant Average Selling Price (ASP), 2020-2031
1.3 China Daridorexant Market Size and Forecast
1.3.1 By Consumption Value, China Daridorexant Market Size, 2020-2031
1.3.2 By Sales Quantity, China Daridorexant Market Size, 2020-2031
1.3.3 China Daridorexant Average Selling Price (ASP), 2020-2031
1.4 Share of China Daridorexant Market with Respect to the Global Market
1.4.1 By Consumption Value, China Daridorexant Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Daridorexant Market Share in Global, 2020-2031
1.4.3 Daridorexant Market Size: China VS Global, 2020-2031
1.5 Daridorexant Market Dynamics
1.5.1 Daridorexant Market Drivers
1.5.2 Daridorexant Market Restraints
1.5.3 Daridorexant Industry Trends
1.5.4 Daridorexant Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Daridorexant, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Daridorexant, Global Market Share by Company, 2020-2025
2.3 Daridorexant Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Daridorexant Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Daridorexant Concentration Ratio
2.6 Global Daridorexant Mergers & Acquisitions, Expansion Plans
2.7 Global Daridorexant Manufacturers Product Type
2.8 Head Office and Daridorexant Production Site of Key Manufacturer
2.9 Daridorexant Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Daridorexant, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Daridorexant, China Market Share by Company, 2020-2025
3.3 China Daridorexant Daridorexant Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Daridorexant Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Daridorexant Capacity by Region
4.3 Global Daridorexant Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Daridorexant Production by Region, 2020-2031
4.5 Global Daridorexant Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Daridorexant Industry Chain
5.2 Daridorexant Upstream Analysis
5.2.1 Daridorexant Core Raw Materials
5.2.2 Main Manufacturers of Daridorexant Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Daridorexant Production Mode
5.6 Daridorexant Procurement Model
5.7 Daridorexant Industry Sales Model and Sales Channels
5.7.1 Daridorexant Sales Model
5.7.2 Daridorexant Typical Distributors

6 Sights by Type
6.1 Daridorexant Classification by Type
6.1.1 25mg
6.1.2 50 mg
6.2 by Type, Global Daridorexant Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Daridorexant Consumption Value, 2020-2031
6.4 by Type, Global Daridorexant Sales Quantity, 2020-2031
6.5 by Type, Global Daridorexant Average Selling Price (ASP), 2020-2031

7 Sights by Dosage Form
7.1 Daridorexant Classification by Dosage Form
7.1.1 Tablets
7.1.2 Other
7.2 by Dosage Form, Global Daridorexant Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Dosage Form, Global Daridorexant Consumption Value, 2020-2031
7.4 by Dosage Form, Global Daridorexant Sales Quantity, 2020-2031
7.5 by Dosage Form, Global Daridorexant Average Selling Price (ASP), 2020-2031

8 Sights by Research Attributes
8.1 Daridorexant Classification by Research Attributes
8.1.1 Original Drug
8.1.2 Generic Drug
8.2 by Research Attributes, Global Daridorexant Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Research Attributes, Global Daridorexant Consumption Value, 2020-2031
8.4 by Research Attributes, Global Daridorexant Sales Quantity, 2020-2031
8.5 by Research Attributes, Global Daridorexant Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Daridorexant Segment by Application
9.1.1 Hospital and Clinic
9.1.2 Retail Pharmacies
9.1.3 Other
9.2 by Application, Global Daridorexant Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Daridorexant Consumption Value, 2020-2031
9.4 by Application, Global Daridorexant Sales Quantity, 2020-2031
9.5 by Application, Global Daridorexant Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Daridorexant Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Daridorexant Consumption Value, 2020-2031
10.3 By Region, Global Daridorexant Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Daridorexant Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Daridorexant Market Size Market Share
10.5 Europe
10.5.1 Europe Daridorexant Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Daridorexant Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Daridorexant Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Daridorexant Market Size Market Share
10.7 South America
10.7.1 South America Daridorexant Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Daridorexant Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Daridorexant Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Daridorexant Consumption Value, 2020-2031
11.3 By Country, Global Daridorexant Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Daridorexant Market Size, 2020-2031
11.4.2 by Type, United States Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Daridorexant Market Size, 2020-2031
11.5.2 by Type, Europe Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Daridorexant Market Size, 2020-2031
11.6.2 by Type, China Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Daridorexant Market Size, 2020-2031
11.7.2 by Type, Japan Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Daridorexant Market Size, 2020-2031
11.8.2 by Type, South Korea Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Daridorexant Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Daridorexant Market Size, 2020-2031
11.10.2 by Type, India Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Daridorexant Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Daridorexant Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Daridorexant Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 Idorsia
12.1.1 Idorsia Company Information, Head Office, Market Area, and Industry Position
12.1.2 Idorsia Daridorexant Models, Specifications, and Application
12.1.3 Idorsia Daridorexant Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 Idorsia Company Profile and Main Business
12.1.5 Idorsia Recent Developments
12.2 Simcere Pharmaceutical
12.2.1 Simcere Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
12.2.2 Simcere Pharmaceutical Daridorexant Models, Specifications, and Application
12.2.3 Simcere Pharmaceutical Daridorexant Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Simcere Pharmaceutical Company Profile and Main Business
12.2.5 Simcere Pharmaceutical Recent Developments
12.3 Nxera Pharma
12.3.1 Nxera Pharma Company Information, Head Office, Market Area, and Industry Position
12.3.2 Nxera Pharma Daridorexant Models, Specifications, and Application
12.3.3 Nxera Pharma Daridorexant Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Nxera Pharma Company Profile and Main Business
12.3.5 Nxera Pharma Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Daridorexant should grow from US$ 73.57 million in 2024 to US$ 812 million by 2031, with a CAGR of 28.0% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Daridorexant

According to YH Research, the global market for Daridorexant should grow from US$ 73.57 million in 2024 to US$ 812 million by 2031, with a CAGR of 28.0% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Daridorexant, sold under the brand name Quviviq, is a medication used to treat insomnia. It is an orexin receptor antagonist, specifically targeting both OX1 and OX2 receptors. This dual mechanism helps regulate sleep-wake cycles, making it effective for improving sleep onset and maintenance. Unlike benzodiazepines or Z-drugs, daridorexant does not interact with GABA receptors, offering a distinct way to manage sleep disorders.

The medication is taken orally and has a relatively short elimination half-life of around 8 hours, with a peak effect occurring within 1 to 2 hours after administration. Common side effects include headache, somnolence (sleepiness), and fatigue. Daridorexant was approved for use in the United States in January 2022 and became available in May 2022. It was also approved in the European Union in April 2022, marking the first orexin receptor antagonist to be available there. However, it is classified as a Schedule IV controlled substance in the United States, indicating a modest potential for misuse.

Daridorexant provides an alternative to traditional sleep medications, offering a distinct mechanism of action that may reduce the risk of dependence and tolerance associated with other sleep aids.In 2024, global sales of Daridorexant reached 3.94 million tablets, with an average unit price of USD 17.56 per tablet and an average gross profit margin of 71.2%.

In the U.S. and Europe, Daridorexant has entered a phase of rapid commercial expansion, supported by favorable clinical differentiation and growing physician adoption. Within the European Union, it is the most recent DORA approved by the EMA for improving both nighttime sleep and daytime functioning—an indication that broadens its clinical appeal beyond sleep onset and maintenance alone. Compared with other DORAs, its pharmacokinetic profile and well-balanced efficacy-safety ratio contribute to higher treatment adherence and positive real-world outcomes.

From a commercial standpoint, Daridorexant’s global rollout reflects a strategic blend of licensing, distribution, and market access initiatives. Regional partnerships enable efficient regulatory navigation and localized market penetration, ensuring coverage across hospitals, retail pharmacies, and online prescription platforms. Reimbursement listings in select countries further enhance patient accessibility, reinforcing uptake momentum. The integration of pharmacovigilance and patient-reported outcomes into post-marketing surveillance also supports sustained physician confidence and long-term safety validation.

Market uptake has been strongest in North America, Western Europe, and Japan, where supportive healthcare infrastructure and awareness campaigns accelerate adoption. In emerging markets such as China, Daridorexant’s entry underscores the expanding recognition of DORA-based therapeutics as the next-generation standard for insomnia care. Continued emphasis on education, real-world data generation, and stable supply chains will be critical to maintaining its growth trajectory.

Overall, Daridorexant exemplifies the evolution of insomnia therapeutics toward mechanism-driven, safety-conscious innovation. Its combination of differentiated pharmacology, robust clinical data, and strategic commercialization positions it as a leading agent in the global sleep medicine landscape—poised to define the post-benzodiazepine era of pharmacological sleep management.

This report studies and analyses global Daridorexant status and future trends, helps the client to determine the Daridorexant market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Daridorexant, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Daridorexant market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Daridorexant sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Daridorexant sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Daridorexant key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Daridorexant key producing regions, capacity, production, and year over year growth
(6) Daridorexant industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Idorsia
    Simcere Pharmaceutical
    Nxera Pharma

Market segment by Type, covers
    25mg
    50 mg

Market segment by Dosage Form, covers
    Tablets
    Other

Market segment by Research Attributes, covers
    Original Drug
    Generic Drug

Market segment by Application, can be divided into
    Hospital and Clinic
    Retail Pharmacies
    Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Daridorexant product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Daridorexant market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Daridorexant market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Daridorexant, percent & CAGR, 2020-2031
Chapter 5: Daridorexant industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.